Specialty Pharmacy

Messaging based on patient medical records allow for more personalized care in HIV and other conditions.

Top news of the day from across the health care landscape.

The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.

Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.

The trial is the first to compare Xeljanz alone or in combination with MTX versus adalimumab plus MTX.

Boehringer Ingelheim seeks to launch its biosimilar to Humira.

Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.

Two KEYNOTE trials were placed on full clinical hold and 1 partial clinical hold.

Abatacept (Orencia) receives approval for third autoimmune condition.

Research may lead to the development of safer therapies for pregnant women with rheumatoid arthritis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The approval greatly expands treatment options for rare inherited blood disorder.

Scientists highlight the potential use of exosomes to detect and treat diseases.

Changing from a biologic to a biosimilar can create insecurity among patients with RA.

Top articles of the week from Specialty Pharmacy Times.

Elevated protein levels may indicate a need for both chemotherapy and surgery for colon cancer.

Anti-fungal therapy may prove beneficial in patients with Crohn’s disease.

Top news of the day from across the health care landscape.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how to increase the utilization of biosimilars across the industry.

Researchers focus on generating a robust HIV-neutralizing antibody response.

Grape compounds may be an effective treatment option for colon cancer patients.

A specific immune T cell protects patients with lung cancer.

Clinical trial shows efficacy of Janus kinase inhibitor and methotrexate.

Mathematical model brings scientists a step closer to developing total viral suppression strategies among patients with HIV.

Sandoz has the highest number of biosimilars approved in Europe.

Some hair care products may cause increased cancer risk.

Top news of the day from across the health care landscape.

Waiting to get treatment for breast cancer results is worse survival outcomes.